SCHEMBL4428068

SCHEMBL4428068

CC(=O)C(c1ccc(C(F)(F)F)cc1)c1cc(C)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
HDAC4 P56524 2/20 0.39
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 2/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
PDE2A O00408 3/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
UTS2R Q9UKP6 1/20 0.36
APP P05067 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4441486 0.83 NR1I2 (0.40) HDAC4
SCHEMBL4433334 0.81 HDAC4 (0.52) AKR1C3AKR1C2HDAC4CES2CES1
SCHEMBL4432365 0.80 AKR1C3 (0.43) AKR1C3AKR1C2HDAC4CES2CES1
SCHEMBL4431561 0.80 AKR1C3 (0.48) AKR1C3AKR1C2HDAC4CES2CES1
SCHEMBL4441390 0.76 CNR1 (0.43) AKR1C3AKR1C2HDAC4CES2CES1
SCHEMBL4436009 0.75 MEN1 (0.43) HDAC4CES2CES1PDE2AHDAC3
SCHEMBL4432335 0.74 CES2 (0.41) AKR1C3AKR1C2CES2CES1PDE2A
SCHEMBL4436353 0.73 AKR1C3 (0.40) AKR1C3AKR1C2HDAC4CES2CES1
SCHEMBL2304585 0.72 ACP3 (0.56) CES2CES1
SCHEMBL4433967 0.71 ACP3 (0.41) HDAC4CES2CES1PDE2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed